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ABSTRACT 
 
The expression of focal adhesion kinase (FAK), a non-receptor cytoplasmic tyrosine 
kinase, is often upregulated in many cancer types. FAK influences cellular adhesion 
and migration, as well as significantly mediating downstream signalling to 
components involved in cellular proliferation and survival. Many of these cellular 
pathways are facilitated by the interaction of FAK with epidermal growth factor 
receptor (EGFR), which is overexpressed in human squamous cell carcinoma. This 
cancer type is highly prevalent in South Africa and is characterized by extremely 
aggressive clinical behaviour and very poor patient prognosis. The aim of this study 
was to investigate FAK expression, localization, and the effects of EGFR activation 
on the expression and tyrosine phosphorylation status of FAK in order to shed light 
on the migratory behaviour of human oesophageal squamous cell carcinoma. This is 
the first study that semi-quantifiably details FAK expression in 5 South African 
human oesophageal squamous cell carcinoma cell lines as demonstrated by western 
blot analysis. Furthermore, as shown by indirect immunofluorescence, FAK is 
localized to focal contacts within migratory structures as well as being abundantly 
present within the cytoplasm of the oesophageal squamous cell carcinoma cell lines. 
Localization of FAK to the migratory front of these cells may promote focal 
adhesion turnover and stimulate cell migration in these cell lines. This study is also 
the first demonstration in this cancer type that illustrates the modulation of the 
expression, cellular localization, proteolytic cleavage and tyrosine phosphorylation 
status of FAK by active EGFR. These findings may uncover some of the molecular 
mechanisms by which upregulated cell movement influences the metastatic 
behaviour of this cancer. Furthermore, the results presented in this study identify 
FAK as a key candidate for anti-cancer therapy in squamous cell carcinoma of the 
oesophagus. 
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